How frequently should testosterone levels be rechecked in adult men?

How Often to Retest Testosterone Levels

Serum testosterone should be measured 3–6 months after initiating therapy to guide dose adjustment, then symptoms must be reassessed at 12 months with therapy discontinued if sexual function has not improved. 1

Initial Monitoring Window

• Measure testosterone 3–6 months after starting therapy to ensure levels fall within the mid-normal range (approximately 400–700 ng/dL). 1
• Dose adjustments should be based on these results, with the timing of blood draw depending on formulation:
  • For intramuscular testosterone enanthate: measure midway between injections 1
  • For transdermal gel: measure in the morning before the next application 1

Timing of Blood Draw Matters

• Always obtain morning samples before 11:00 AM to account for diurnal variation in testosterone production. 2
• Testosterone levels measured between 8–11 AM are significantly higher (411.7 ng/dL) compared to afternoon draws (344.3 ng/dL from 2–5 PM), even in older men. 3
• In equivocal cases (7.0–12.5 nmol/L), obtain at least one additional morning measurement to account for intra-individual variability. 2

Mandatory 12-Month Reassessment

• At 12 months, reassess symptoms—particularly sexual function—and discontinue therapy if there is no improvement. 1
• This is critical because testosterone therapy is indicated only for sexual dysfunction in men with age-related low testosterone, not for low energy, reduced vitality, or cognitive decline. 1
• Sexual function improves modestly (effect size 0.35–0.45), while benefits for other symptoms are minimal. 1

Ongoing Monitoring Beyond Initial Period

While the highest-quality guideline evidence focuses on the 3–6 month and 12-month timepoints, additional monitoring considerations include:

• PSA monitoring should follow established protocols, with biopsy or urology referral if PSA rises above 4.0 ng/mL or increases by more than 1.0 ng/mL in the first 6 months, or by more than 0.4 ng/mL/year thereafter. 4
• Hematocrit monitoring is important given testosterone's effect on red blood cell production, though specific intervals are not detailed in the highest-quality guidelines reviewed. 5

Common Pitfalls to Avoid

• Do not rely on afternoon or evening testosterone measurements—up to 91% of tested men in one study had blood drawn outside the recommended 7 AM–12 PM window. 6
• Do not continue therapy indefinitely without symptom reassessment—most efficacy data derive from trials lasting less than 1 year, leaving long-term benefits uncertain. 1
• Consider free or bioavailable testosterone in obese or diabetic men with low SHBG, as total testosterone may be misleadingly low in these populations. 7